Available Technologies

Priority Assets


Therapeutics 

Synergistic Activity For Pevonedistat With Braf Kinase Inhibitors In Braf Melanoma

Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein

Treating Clostridium Infection and Preventing Recurrence

Immune Mechanisms of Protection from Hypervirulent C. difficile Infection

Augmenting Stress Induced Erythropoiesis

Novel Transcription Factor Inhibitor As Treatment For Epithelial Cell Cancers

Tissue Engineered Muscle Repair Temr For Treatment Of Volumetric Muscle Loss

mRNA Sponging In Nucleotide Repeat Disorders

AAV Targets Cardiac Myofibroblasts

Broad Spectrum Biofilm Inhibition By A Small Bacterial Peptide

Combating Multidrug Resistant Bacteria Using Chemokine-Derived Antimicrobial Peptides

Novel Hemoglobin Peptide For Treatment Of Cardiovascular Disease

Target Specific Delivery Of Therapeutic Agents For Cardiac Infarction Treatment

Next Gen Therapeutics For Ovarian Cancer

Sphingosine Kinase 2 Inhibitors For Acute Kidney Injury Aki And Chronic Kidney Disease Ckd

Sphingosine Kinase Inhibitors For Multiple Sclerosis

Isoform Selective Sodium Channel Inhibitors For The Suppression Of Epileptic Seizures

Combination Of Ifnγ And Tlr2 6 Agonists For The Treatment Of Melanoma

Compositions And Methods For Preventing And Treating Rhinovirus Infection

Compositions And Methods For Treating Diabetic Retinopathy

Treatment Of Diabetic Retinopathy With Micro Rna Let 7B

Novel Combination Therapy Effective Against Glioblastoma Gbm

Tissue Engineered Muscle Repair (TEMR) for Treatment of Volumetric Muscle Loss